U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval ...Middle East

Devdiscourse - Opinion
U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval
An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech SE COVID-19 vaccine for people age 16 and older, an important step that could help accelerate vaccine mandates in the United States. The Food and Drug Administration last week granted full approval to the vaccine that was previously available under the agency's emergency use authorization (EUA), which had allowed the shots to be rolled out rapidly to Americans.

Hence then, the article about u s vaccine advisers unanimously favor pfizer biontech shot after approval was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval )

Apple Storegoogle play

Last updated :

Also on site :